Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

TRANSTHERA-B

10.310
-0.070-0.67%
Volume:4.54M
Turnover:46.60M
Market Cap:4.20B
PE:-11.63
High:10.440
Open:10.440
Low:10.120
Close:10.380
52wk High:679.500
52wk Low:9.010
Shares:407.00M
HK Float Shares:312.00M
Volume Ratio:0.52
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.887
ROE:-62.88%
ROA:-32.06%
PB:8.64
PE(LYR):-11.63
PS:- -

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
TRANSTHERA-B
Exchange:
SEHK
Establishment Date:
2014
Employees:
- -
Office Location:
Building 9, Accelerator Phase 2,3rd Floor,Biotech and Pharmaceutical Valley,Jiangbei New Area,Nanjing,Jiangsu Province,China
Website:
http://www.transtherabio.com
Zip Code:
210032
Phone:
86 25 5821 6200
Fax:
- -
Introduction:
TransThera Sciences (Nanjing) Inc is a China-based biopharmaceutical company principally focusing on discovering and developing innovative small molecule therapies for oncology, inflammatory and cardiometabolic diseases. The Company's core product Tinengotinib is a registrational clinical stage, internally discovered and developed, MTK inhibitor indicated for certain relapsed or refractory, drug-resistant solid tumors. The Company's oncology pipeline includes TT-00973 (against AXL), TT-01488 (for hematologic malignancies), TT-01688 (for inflammatory diseases) and TT-00920 (for chronic heart failure). The products are capable of being efficacious in a broad range of cancer types (including prostate cancer, HCC, breast cancer, and BTC). It is also applied to cure hepatocellular carcinoma, breast cancer, biliary tract cancer and Pan-FGFR solid tumor.

Directors

Name
Position
WU Yong Qian
Chairman of the Board,Executive Director,Chairman of the Strategic and Development Committee,Member of the Nomination Committee
WU Di
Executive Director
GU Zhong Xin
Director,Member of the Strategic and Development Committee,Member of the Remuneration and Assessment Committee,Audit Committee Member
XU Hai Yin
Independent Director,Member of the Strategic and Development Committee,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
LI Shu Pai
Independent Director,Audit Committee Chairman
FENG Wei Bo
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member

Shareholders

Name
Position
WU Yong Qian
CEO
WU Di
General Manager,CFO
FENG Jie
Vice General Manager,Board Secretary,Corporate Secretary
SUN De Long
COO
Wong Tik
Corporate Secretary
FAN Jing
Other Senior Executives
CUI Song Xi
Other Senior Executives
PENG Peng
Other Senior Executives
SHENG Ze Juan
Other Senior Executives
SUN Cai Xia
Other Senior Executives
PANG Ya Jing
Other Senior Executives